Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis
Introduction
It was proposed in 2003 that the anti-parkinsonian actions of cannabinoid (CB)1 receptor antagonists involve the counteraction of antagonistic CB1/dopamine (D)2 receptor interactions in CB1/D2 heteromeric complexes (Fuxe et al., 2003). Subsequent work also indicated the existence of CB1/D2 heteromers in HEK-293 cell lines (Kearn et al., 2005) based inter alia on co-immunoprecipitation experiments with the putative CB1/D2 heteromers becoming enhanced by concurrent agonist stimulation (Kearn et al., 2005). The cellular and sub-cellular localization of CB1 receptor and D2 receptors in the basal ganglia have been described in detail (Agnati et al., 2005, Egertova and Elphick, 2000, Khan et al., 1998, Matyas et al., 2006, Missale et al., 1998, Pickel et al., 2006). The evidence suggests a co-location of CB1 and D2 striatal receptors predominantly in the soma and dendrites of the ventral of striato-pallidal GABA neurons and also in cortico-striatal glutamate terminals where A2A receptors are also present (see Fuxe et al., 2005, Katona et al., 2006, Pickel et al., 2006, Uchigashima et al., 2007, Yin and Lovinger, 2006).
In the present study, the existence of CB1/D2 heteromers has been further established in cell lines using FRET-based analysis as well as demonstrating the existence of antagonistic CB1/D2 receptor interactions at the agonist recognition level in rat striatal membranes and by using receptor autoradiography in the rat nucleus accumbens. Through in vivo pharmacological analysis of D2 receptor agonist-induced hyperlocomotion, we have further demonstrated the existence of antagonistic CB1/D2 receptor interactions with an involvement of adenosine (A)2A receptor activation.
Section snippets
Autoradiography
Male specific free pathogen Sprague-Dawley rats (N = 8, 6 months old, weighted 275 ± 3 g) were provided by IFFA-CREDO (CHARLES RIVER, France). Animals were handled under standard conditions during 2 weeks. All animals were maintained in humidity and temperature controlled (20–22 °C) room under a 12:12-h light/dark cycle (lights on 08:00 and off 20:00 h). Food and water were available ad libitum. All experiments were performed between 09:00 and 13:00 in consideration of the animals' circadian rhythm.
Heteromerization of CB1 and D2 receptors in living cells
The formation of CB1–D2 receptor heteromers was demonstrated by using the FRET technique in cells transfected with fusion proteins consisting of each receptor and a fluorescent protein, either GFP2 or YFP. Expression of fusion proteins was assessed by Western blot and immunocytochemistry (data not shown). As seen in Fig. 1, a clear-cut positive FRET signal was observed in living cells co-transfected with the cDNA of vectors encoding for D2-GFP2 and CB1-YFP similar to the FRET signal obtained
Discussion
Previously, based on behavioral experiments, it has been proposed that CB1 and D2 receptors could antagonistically interact within CB1/D2 heteromeric complexes in striato-pallidal GABA neurons (Fuxe et al., 2003) and where co-immunoprecipitation assays have given further evidence for this proposal (Kearn et al., 2005). Here, strong evidence supporting direct interactions between CB1 and D2 receptors through CB1/D2 heteromerization is provided. Evidence indicating antagonistic CB1/D2 receptor
Acknowledgements
This study was supported by a Grant from the Swedish Research Council (K2006-04X-00715 to K. Fuxe), a Grant from the Spanish Ministry of Education and Science (SAF2005-00170 to C. Lluis and SAF2006-05481 to R. Franco) and by the statutory funds from the Institute of Pharmacology, Polish Academy of Sciences (M. Filip).
References (28)
- et al.
Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer
J. Biol. Chem.
(2003) - et al.
Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies
Eur. J. Pharmacol.
(2007) - et al.
Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine
Brain Res.
(2006) - et al.
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia
Neuroscience
(2006) - et al.
Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity
Pharmacol. Biochem. Behav.
(2000) - et al.
Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum
Neuropharmacology
(2001) - et al.
Binding of [3H]MSX-2 (3-(3-hydroxypropyl)-7-methyl-8-(m-methoxystyryl)-1-propargylxanthine) to rat striatal membranes – a new, selective antagonist radioligand for A2A adenosine receptors
Eur. J. Pharm. Sci.
(2000) - et al.
Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats
Eur. J. Pharmacol.
(1998) - et al.
Role of the endogenous cannabinoid system in the regulation of motor activity
Neurobiol. Dis.
(1998) - et al.
Spectral imaging and linear un-mixing enables improved FRET efficiency with a novel GFP2–YFP FRET pair
FEBS Lett.
(2002)
Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases
Neuromolecular Med.
Cannabinoid action depends on phosphorylation of dopamine- and cAMP-regulated phosphoprotein of 32 kDa at the protein kinase A site in striatal projection neurons
J. Neurosci.
Regulation of protein kinase A-dependent phosphorylation of DARPP-32 by delta9-THC
Neuropharmacology
Striatal Adenosine A2A and Cannabinoid CB1 Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of Cannabinoids
Neuropsychopharmacology
Cited by (146)
Using caffeine as a chemical means to induce flow states
2024, Neuroscience and Biobehavioral ReviewsAdenosine A<inf>2A</inf>-cannabinoid CB<inf>1</inf> receptor heteromers in the brain: From trans-inhibition to trans-activation
2023, Neurobiology and Physiology of the Endocannabinoid SystemProtein-protein allosteric effects on cannabinoid receptor heteromer signaling
2022, Allosteric Modulation of G Protein-Coupled ReceptorsReceptor mechanisms underlying the CNS effects of cannabinoids: CB<inf>1</inf> receptor and beyond
2022, Advances in PharmacologyHeteromerization of dopaminergic receptors in the brain: Pharmacological implications
2021, Pharmacological ResearchCitation Excerpt :The direct physical interaction of the two receptors was further supported and confirmed by their functional interactions [155–158]. Although activation of the individual protomers with their respective agonists leads to signaling cascade via Gαi/o, the simultaneous co-activation of both receptors switches the signaling cascade from the Gαi/o to Gαs/olf, leading to altered signaling [63,155,156]. Moreover, recent studies revealed that this heterodimeric specific signaling requires the bidirectional allosteric interaction of the two receptors as lack of activation of either receptor abolishes the observed effect i.e. signal switching and co-internalization [155,156].